Professor Danny Rischin
Professor Danny Rischin is the Director of Medical Oncology at the Peter MacCallum Cancer Centre. A highly productive clinician‐researcher, he has made significant and sustained contributions to advancing knowledge and in developing new therapies for head and neck cancer and cutaneous squamous cell carcinoma. Professor Rischin is an international leader in head and neck cancer, […]
Professor Alicia Oshlack
Professor Alicia Oshlack is an expert in Computational Biology, who has developed a range of widely used bioinformatics analysis methods that underlie many of the genomic technologies used today. Her extensive analytical and computational skills and research contributions are now part of the standard approaches for the analysis of RNA sequencing and human methylation investigations. […]
Professor Colette McKay
Professor Colette McKay has conducted world-leading interdisciplinary research that vitally contributed to the efficacy of Australia’s most successful medical device, the cochlear implant. Her work, which combines behavioural studies with mathematical modelling, electrophysiology, and brain imaging, has derived important information about how the brain’s auditory pathways process electrical stimulation. She has applied this knowledge to […]
Professor Kirsten Howard
Professor Kirsten Howard is an internationally acknowledged leader in health economics. She is Co-Director of the Menzies Centre for Health Policy and Economics, and leads a health economics group with internationally recognised expertise in patient and community preference elicitation, quality of life and wellbeing measurement, and economic evaluation. With research funding as CI in excess […]
Professor Christine Jenkins
Professor Christine Jenkins (Head of the Respiratory Group at The George Institute for Global Health) is a renowned authority in the field of airways diseases ‐ in particular Asthma and Chronic Obstructive Pulmonary Disease ‐ whose contributions have spanned from fundamental studies to large NHMRC‐funded trials (230+ publications; H‐index 50). Professor Jenkins has also contributed […]
Professor Jonathan Golledge
Professor Jonathan Golledge is an NHMRC Practitioner Fellow and vascular surgeon recognised as an international leader in artery disease. During the last 15 years, he established a translational research program which has culminated in bringing multiple new drugs and management approaches to clinical trials. The largest of these, testing a repurposed drug for artery weakening, […]